Ovarian volume and PCOS: a controversial issue

References

• Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456–88.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Isaoglu U, Delibas IB, et al. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J Obstet Gynaecol Res 2011;37:1020–6.
   PubMed Web of Science ®Google Scholar
• Andersen AN, Balen A, Platteau P, et al. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Hum Reprod 2008;23:1424–30.
   PubMed Web of Science ®Google Scholar
• Lass A, Vassiliev A, Decosterd G, et al. Relationship of baseline ovarian volume to ovarian response in World Health Organisation II anovuvulatory patients who underwent ovulation induction with gonadotropins. Fertil Steril 2002;78:265–9.
   PubMed Web of Science ®Google Scholar
• Ramezanali F, Ashrafi M, Hemat M, et al. Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-müllerian hormone. Reprod Biomed Online 2016;32:503–12.
   PubMed Web of Science ®Google Scholar
• Sahmay S, Atakul N, Oncul M, et al. Serum anti- mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;170:157–61.
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JS, von Bergh AR, et al. Anti- mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83.
   PubMed Web of Science ®Google Scholar
• La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 2014;124–40.
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957–62.
   PubMed Web of Science ®Google Scholar
• Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10:107–17.
   PubMed Web of Science ®Google Scholar
• Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006;132:191–206.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28–38.
   PubMed Web of Science ®Google Scholar
• Balen AH, Laven JS, Tan SL, et al. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505–14.
   PubMed Web of Science ®Google Scholar
• Köninger A, Sauter L, Edimiris P, et al. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Hum Reprod 2014;29:518–24.
   PubMed Web of Science ®Google Scholar
• Xi W, Yang Y, Mao H, et al. Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome. J Ovarian Res 2016;119:3.
   Google Scholar
• Mahran A, Abdelmeged A, El-Adawy AR, et al. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J Clin Endocrinol Metab 2013;98:4170–5.
   PubMed Web of Science ®Google Scholar
• Piltonen T, Morin-Papunen L, Koivunen R, et al. Serum anti- mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005;20:1820–6.
   PubMed Web of Science ®Google Scholar
• Laven JS, Mulders AG, Visser JA, et al. Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318–23.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011;26:3123–9.
   PubMed Web of Science ®Google Scholar
• Villarroel C, Merino PM, López P, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti- mullerian hormone. Hum Reprod 2011; 26:2861–8.
   PubMed Web of Science ®Google Scholar
• Romualdi D, Di Florio C, Tagliaferri V, et al. The role of anti- müllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes. Reprod Sci 2016;23:655–61.
   PubMed Web of Science ®Google Scholar
• Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet 2016;293:447–56.
   PubMed Web of Science ®Google Scholar
• Hassa H, Tanir HM, Yildiz Z. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Arch Gynecol Obstet 2006;274:227–32.
   PubMedGoogle Scholar
• Pasquali R, Zanotti L, Fanelli F, et al. Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J Clin Endocrinol Metab 2016;101:2013–22.
   PubMed Web of Science ®Google Scholar
• Dewailly D. Diagnostic criteria for PCOS: is there a need for a rethink? Best Pract Res Clin Obstet Gynaecol 2016;37:5–11.
   PubMed Web of Science ®Google Scholar